FDA Investigator Paul Mouris

Paul Mouris has inspections in 12 countries as of 07 Nov 2023. Paul Mouris has collaborated with a combinined 6697 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
133
Last Inspection Date:
07 Nov 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
100003786
Country:
United States of America, Italy, Brazil, India, Taiwan, United Kingdom of Great Britain and Northern Ireland, Mexico, Canada, Spain, China, Germany
Co-Investigator(s):
A Williams, Abby Lmozeke Baker, Addam S Reynolds, Ademola O Daramola, Alan P Kurtzberg, Alia Legaux, Alice S Tsao, Alicia M Mozzachio, Althea A Williams, Amatul H Marium, Amber D Brodas, Amir Alavi, Amy M Cramer, Amy N Chen, Amy W Yan Mai, Anastasia M Shields, Andrew F Cohen, Angela E Glenn, Anissa M Vargas, Ann B Okon, Ann M Stewart, Anna M Alexander, Annemarie B Randow, Annemarie Bodnar, Anthony A Charity, Antonina Aydanian, April L Young, Arduino Frankovic, Arsen Karapetyan, Atul J Agrawal, Aziz A Mamur, Barbara J Maulfair, Barbara Jwilimczyk Macri, Benton M Ketron, Bijoy Panicker, Bo Chi, PhD, Brandy N Lepage, Brenda W Uratani, PhD, Brian J Ryan, Bruce G Cooper, Bruce H Mccullough, Byungja E Marciante, C Tyfrans Francis, Candace Y Gomez Broughton, Carolyn J Cook, Caryn M Mcnab, Charanjeet Jassal, Charisse K Green, Charles Jewell, Cheryl L Watson, Christian Parra, Christina K Theodorou, Christine M Rivera, Clifton C Francis, Cody D Rickman, Crystal Monroy, D Jenny Argiropoulos, Daniel J Grabicki, Danna E Solorzano, David K Lau, David M Beltran, David M Mcnew, David R Delucia, Dawn L Wydner, Demetria J Arpropractor, Demitria J Argiiropoulos, Demitria J Argiropolous, Demitria J Argiropoulos, Demitria J Xiradakis, Dennis E Guilfoyle, PhD, Devaughn Edwards, Diane L Raccasi, Dipesh K Shah, Doan T Nguyen, PharmD, Donald G Gordon, Dongping Dai, PhD, Douglas C Kovacs, Dr. Barbara D Paul, PhD, Dr. Carmelo Rosa, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Elaine E Gilfillan, Eric J Reisenauer, Erica B Raphael, Erika E Englund, PhD, Erin L Nagel, Evan Tong, Evelyn Taha, Felix Maldonado, Frank Verni, Frederick Razzaghi, Freyja V Lynn, Gam S Zamil, Gary J Lehr, Gary T Greco, Geoffrey K Wong, George C Amedro, George J Flynn, Gerardo Z Vazquez, Gifford Whitehurst, Jr, Gray, Gregson A Joseph, Gregson Joseph, Guerlain Ulysse, Harry J Brewer, Helen B Ricalde, Huascar Batista, Iraida Ortiz, Iram R Hassan, PhD, Irina Gaberman, Isaac N Baah, J Paul Kirwan, PhD, Jacqueline Mdiaz Albertini, Jacqueline S Warner, James A Liubicich, James A Liubieich, James C Maclaughlin, James D Bridges, James M Mason, James R Birkenstamm, Jane Chen, Janet A Rajan, Jay T Wong, Jazmine N Brown, Jeffery A Hangartner, Jennifer L Bridgewater, Jens Fricke, Joanne M Schlossin, Joey V Quitania, Jogy George, John A Podsadowski, Johnna L Bleem, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Jose Martinez, Jr, Jose O Hernandez, Jose Ohernandez Guzman, Jose R Hernandez, Joseph J Vannelli, Joseph Maselli, Joseph Milcetic, Joseph R Lambert, Joy P Matthias, Juanita P Versace, Judy Keihl, Juliana M Badalucco, Julie D Bringger, Junho Pak, Justin A Boyd, Kalavati Suvarna, PhD, Kara D Dobbin, Karen L Kosar, Karishma G Gopaul, Kazi Rafiquzzaman, Kelli F Dobilas, Kellie Leveille, Kenneth G Klobus, Kenneth H Williams, Kenneth R Merritt, Kerry D Noto, Kerun Hardeo, Kevin A Gonzalez, Kham Phommachanh, Kim Lthomas Cruse, Kim M Downing, Kim Thomasc Rice, Kimberley A Ricketts, Krishna Ghosh, PhD, Kristina L Conroy, Kristy A Zielny, Kwong Lee, Kwong P Lee, L Gnnmassimia Massimilla, PharmD, Lakshmi Narasimhan, PhD, Larry K Austin, Lata C Mathew, PhD, Laura Fontan, MS, Lauren L Vajo, Laurimer Kuilan Torres, Lawrence W Farina, LCDR Chad N Thompson, LCDR Wilfred A Darang, Leena Thomas, Linda F Murphy, Linda J Eason, Linda M Sacco, Lirissia Mccoy, Lisa Mathew, Loretta Nemchik, Lori P Peters, Lori S Lawless, Luella J Rossi, Manhar R Patel, Marcellinus D Dordunoo, Margaret E Sarles, Margaret M Sands, Maria C Shih, Maria Estrella, Maria Joselopez Barragan, PhD, Marianna Viner, Marie A Fadden, Marie Elena C Puleo, Marjorie A Shapiro, PhD, Mark D Johnson, Marsha W Major, Martha T Olone, Marvin D Jones, Mary Davis Lopez, Mary M Finn, Mate Tolnay, Matthew A Spalazo, Matthew A Sparato, Matthew A Spataro, Matthew D Schnittker, Maxwell Van Tassell, PhD, Melkamu Getie Kebtie, PhD, Meredith L Sheridan, Meredith P Soehl, Investigator, Meyer J Slobotsky, Michael A Charles, Michael E Maselli, Michael F Skelly, PhD, Michael L Casner, Michael L Chasey, Michael Levin, Michael Levine, Michael R Dominick, Michael R Goga, Michael R Klapal, Michael Serrano, Michael Shanks, MS, Michael W Burd, Michelle Y Clark Stuart, Mihaly S Ligmond, Milan S Blake, Milan S Mcgorty, Milos Dokmanovic, PhD, Mindy M Chou, Morgan J Matthews, Mra Mcculloughj, Mra Munizn, Nadeem I Chaudhry, Nancy A Saxenian Emmons, Nancy F Scheraga, Nancy L Rolli, Nancy T Waites, Nayan J Patel, Nebil A Oumer, Neil J Bonzagni, PhD MPH, Nicholas A Violand, Nicholas C Mendiola, Nicole E Knowlton, Niketa Patel, Nur M Faisal, Omotunde O Osunsanmi, Parul M Patel, Patrick C Klotzbuecher, Paul E Stein, Paul L Bellamy, Paul L Figarole, Jr, Paula A Trost, Penny H Mccarver, Perry T Nichols, Peter Abel, Peter Caparelli, Peter E Baker, Peter M Trunk, Peter R Caparelli, Peter R Lenahan, Philip F Istafanos, DMV, MS, Phyllis J Wilson, Prabhu P Raju, Pratik S Upadhyay, DDC, Rachael A Moliver, Rachael O Oyewole, Rafael E Arroyo, Rajiv R Srivastava, Ramon A Hernandez, Raymond T Oji, Rebecca Rodriguez, Regina T Brown, Reyes Candau Chacon, PhD, Richard E Needham, Richard J Friedman, Richard L Friedman, Richard Ledwidge (nmi), PhD, Richard W Thornton, Rita K Kabaso, Rober C Horan, PhD, Robert C Coleman, Robert C Howard, Robert C Steyert, Robert J Martin, Robert Jennings, Robert W Jennings, Rochelle K Kimmel, Roger F Zabinski, Ronald Ifraimov, Rose M Ashley, Ruben C Quintana, Russ E Davis, Russell J Glapion, S Thomas, Saleem A Akhtar, Salvatore N Randazzo, Samina S Khan, Samuel T Walker, Sandra D Thompson, Sangeeta M Khurana, PhD, Santos E Camara, Sarah A Meehan, Sarah B Tanksley, Sarah Kennett, PhD, Sasha M Latonis, Satheesh Thomas, Sayyem H Akbar, Scott E Norris, Scott T Ballard, Shari L Kahn, Simone E Pitts, Sonia E Ortiz, Sony Mathews, Srinivas R Chennamaneni, PhD, Sripal R Mada, PhD, Stacey S Degarmo, Stanley M Shepperson, State Agency, Stella Yuen, Stephanie A Slater, MS, Stephanie T Durso, Stephen J Mottola, Steven M Weinman, Susan F Laska, MS, Susan M Jackson, Susanna E Ford, Analyst, Susant Hadman, Syeda N Mahazabin, Tanya R Syffrard, Tara K Carmody, Tej Poonai, Teresa I Navas, Terri L Dodds, Thomas J Arista, Thomas J Mooney, Thomas S Arista, Thomas W Nojek, Thuy T Nguyen, LCDR, Tina S Roecklein, Tracy M Portelli, Tzanko Stantchev, Uduak M Inokon, Valentino Fiorella, Valerie A Potopsingh, Vanessa M Williams, Vioela J Caze, Vivin George, Walter L Fava, Wayne E Seifert, Wendy G Tan, PhD, Wendy R Blame, William A Warnick, William J Leonard, William M Rennells, Willie Wilson, Winston R Alejo, Xiaokuang Lai, PhD, Xiaoping Guan, Xikui Chen (nmi), PhD, Yumi J Hiramine, Yuyan Liang, Yvins Dezan, Zameer Farouk

Paul Mouris's Documents

Publish Date Document Type Title
November, 2009 EIR American Regent, Inc. - EIR, 2009-11-05
January, 2013 EIR Velocity Pharma LLC - EIR, 2013-01-11
March, 2018 EIR ScieGen Pharmaceuticals, INC. - EIR, 2018-03-14
February, 2008 FDA 483 Taro Pharmaceuticals U.S.A., Inc. - Form 483, 2008-02-01
December, 2012 FDA 483 Novartis Pharmaceuticals Corp. - Form 483, 2012-12-19
November, 2017 EIR SGS India Private Limited - EIR, 2017-11-24
May, 2012 FDA 483 Amneal Pharmaceuticals of New York, LLC - Form 483, 2012-05-15
August, 2022 FDA 483 Quotient Sciences - Philadelphia, LLC - Form 483, 2022-08-16
August, 2009 FDA 483 Strides Pharma, Inc - Form 483, 2009-08-07
May, 2018 EIR MSN Laboratories Private Limited - EIR, 2018-05-25
September, 2012 FDA 483 Cardinal Health 414, LLC - Form 483, 2012-09-13
August, 2019 EIR Shanghai Kyowa Amino Acid Co.,Ltd - EIR, 2019-08-09
January, 2006 FDA 483 Response Epic Pharma, LLC - Form 483R, 2006-02-17
August, 2006 FDA 483 Strides Pharma, Inc - Form 483, 2006-08-11
July, 2004 FDA 483 Response Pfizer Inc. - Form 483R, 2004-08-27
September, 2019 FDA 483 YUNG SHIN PHARM. IND. CO., LTD. - Form 483, 2019-09-12
January, 2012 FDA 483 Novartis Pharmaceuticals Corp. - Form 483, 2012-01-31
June, 2011 FDA 483 Hikma Pharmaceuticals USA, Inc. - Form 483, 2011-06-30
April, 2006 FDA 483 Pfizer Inc. - Form 483, 2006-04-18
September, 2019 EIR YUNG SHIN PHARM. IND. CO., LTD. - EIR, 2019-10-22
May, 2008 EIR SML Acquisition, LLC (aka San-mar Laboratories, Inc) - EIR, 2008-05-08
November, 2009 FDA 483 American Regent, Inc. - Form 483, 2009-11-05
January, 2019 FDA 483 Greenbrier International, Inc - Form 483, 2019-01-18
July, 2006 EIR Barr Laboratories Inc. - EIR, 2006-07-14
October, 2011 FDA 483 Professional Disposables International, Inc. - Form 483, 2011-10-18
February, 2011 FDA 483 Fougera Pharmaceuticals Inc. - Form 483, 2011-02-09
August, 2011 FDA 483 ULTRAtab Laboratories, Inc. - Form 483, 2011-08-02
August, 2012 FDA 483 Columbia Presbyterian Medical Center - Form 483, 2012-08-10
February, 2018 FDA 483 Dsm Nutritional Products GmbH - Form 483, 2018-02-02
April, 2018 FDA 483 CIPLA LIMITED - Form 483, 2018-04-13
April, 2005 FDA 483 Watson Laboratories, Inc. - Form 483, 2005-04-28
January, 2019 FDA 483 Response Greenbrier International, Inc - Form 483R, 2019-02-05
May, 2013 EIR Barr Laboratories Inc. - EIR, 2013-05-17
August, 2006 FDA 483 Sinclair Pharmacal - Form 483, 2006-08-21
May, 2018 FDA 483 Moehs Catalana SL - Form 483, 2018-05-18
December, 2007 FDA 483 CJ Mailing & Fulfillment Inc - Form 483, 2007-12-27
April, 2006 EIR Pfizer Inc. - EIR, 2006-04-18
October, 2005 EIR Barr Laboratories Inc. - EIR, 2005-10-27
September, 2009 FDA 483 Abraxis BioScience - Form 483, 2009-09-17
March, 2018 EIR ScieGen Pharmaceuticals, INC. - EIR, 2018-03-16
July, 2006 FDA 483 Response Barr Laboratories Inc. - Form 483R, 2006-10-03
May, 2013 FDA 483 Barr Laboratories Inc. - Form 483, 2013-05-17
February, 2004 EIR Sandra C. Belmont, M.D. - EIR, 2004-02-10
February, 2004 FDA 483 Sandra C. Belmont, M.D. - Form 483, 2004-02-10
July, 2006 FDA 483 Response Barr Laboratories Inc. - Form 483R, 2007-02-16
April, 2008 FDA 483 Citigroup Biomedical Imaging Center - Form 483, 2008-04-17
March, 2013 FDA 483 Central Admixture Pharmacy Services Inc - Form 483, 2013-03-07
July, 2004 EIR Pfizer Inc. - EIR, 2004-07-29
January, 2007 FDA 483 Ivax Pharmaceuticals Inc A.k.a Teva Pharmaceuticals Usa - Form 483, 2007-01-03
August, 2022 EIR Quotient Sciences - Philadelphia, LLC - EIR, 2022-08-16
October, 2019 FDA 483 YUNG SHIN PHARM. IND. CO., LTD. - Form 483, 2019-10-22
March, 2004 EIR Auxilium Pharmaceuticals, LLC - EIR, 2004-03-08
July, 2004 FDA 483 Pfizer Inc. - Form 483, 2004-07-29
February, 2009 FDA 483 Acorda Therapeutics, Inc. - Form 483, 2009-02-26
March, 2012 FDA 483 GC Hanford Manufacturing Company - Form 483, 2012-03-09
March, 2019 EIR ITS Testing Services (UK) Limited - EIR, 2019-03-15
February, 2007 FDA 483 Novartis Pharmaceuticals Corp. - Form 483, 2007-02-16
March, 2004 FDA 483 Auxilium Pharmaceuticals, LLC - Form 483, 2004-03-08
February, 2018 EIR Dsm Nutritional Products GmbH - EIR, 2018-02-02
January, 2006 FDA 483 Epic Pharma, LLC - Form 483, 2006-01-25
August, 2011 FDA 483 Response ULTRAtab Laboratories, Inc. - Form 483R, 2011-09-09
March, 2009 FDA 483 Novartis Pharmaceuticals Corp. - Form 483, 2009-03-31
April, 2010 FDA 483 Response Contract Pharmacal Corp. - Form 483R, 2010-11-04
March, 2013 FDA 483 IV Solutions of Lubbock - Form 483, 2013-03-20
December, 2013 FDA 483 Chartwell Pharmaceuticals Carmel, LLC - Form 483, 2013-12-23
May, 2008 FDA 483 SML Acquisition, LLC (aka San-mar Laboratories, Inc) - Form 483, 2008-05-08
October, 2008 FDA 483 Professional Disposables International, Inc. - Form 483, 2008-10-29
June, 2011 FDA 483 Response Hikma Pharmaceuticals USA, Inc. - Form 483R, 2011-07-21
May, 2004 FDA 483 Novartis Pharmaceuticals Corp. - Form 483, 2004-05-21
June, 2013 FDA 483 Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer, Inc. - Form 483, 2013-06-21
April, 2005 EIR Watson Laboratories, Inc. - EIR, 2005-04-28
May, 2006 FDA 483 Watson Laboratories, Inc. - Form 483, 2006-05-31
January, 2013 FDA 483 Velocity Pharma LLC - Form 483, 2013-01-11
October, 2012 FDA 483 Pharmascience Inc - Form 483, 2012-10-12
March, 2008 FDA 483 The Feinstein Institutes for Medical Research - Form 483, 2008-03-25
July, 2006 FDA 483 Response Barr Laboratories Inc. - Form 483R, 2006-12-07
October, 2019 EIR YUNG SHIN PHARM. IND. CO., LTD. - EIR, 2019-10-22
September, 2009 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2009-09-17
January, 2006 EIR Epic Pharma, LLC - EIR, 2006-01-25
July, 2012 EIR AMA Laboratories, Inc. - EIR, 2012-07-26
October, 2013 FDA 483 Fougera Pharmaceuticals Inc. - Form 483, 2013-10-31
April, 2010 FDA 483 Contract Pharmacal Corp. - Form 483, 2010-04-28
May, 2018 EIR Moehs Catalana SL - EIR, 2018-05-18
July, 2006 FDA 483 Barr Laboratories Inc. - Form 483, 2006-07-14

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more